Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.63 +0.01 (+0.62%)
As of: Oct 2, 2026 · 12:01 PM EDT

Processa Pharmaceuticals (PCSA) Liabilities from Discontinued Operations (2014 - 2016)

Updated

Processa Pharmaceuticals (PCSA) reported Liabilities from Discontinued Operations of $307,219 for Q1 2016, up 2.3% from the prior quarter.

Analysis

Processa Pharmaceuticals (PCSA) Liabilities from Discontinued Operations (2014 - 2016) Analysis & Trends

At the end of FY2015, Processa Pharmaceuticals posted Liabilities from Discontinued Operations of $300,338, down 33.7% from FY2014.

  • By year, Liabilities from Discontinued Operations came in at $453,193 in FY2014.
  • The Q1 2016 figure ranks as the highest quarterly Liabilities from Discontinued Operations since Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Processa Pharmaceuticals 4.58 Mn 4.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 307,219.00
Dec 31, 2015 300,338.00
Dec 31, 2014 453,193.00
API Access

Processa Pharmaceuticals Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=PCSA&period=max&api_key=YOUR_API_KEY